Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas

NCT04224064 is registered in ClinicalTrials.gov with Institut du Cancer de Montpellier - Val d'Aurelle as lead sponsor.

NCT NCT04224064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04224064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas
Lead sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Phase
Not applicable
Overall status
Recruiting
Start date
August 26, 2020
Completion date
December 31, 2029
Enrollment
158 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atypical lipomatous tumor, liposarcoma